Colon Cancer

Fluorescent nanoparticles clearly identified colonic adenomas — precursors to colorectal cancer — in mice, and the formulation should translate to clinical use in humans. Read More

Chemoresistant SW480 colon cancer cells stained for lipid rafts (green), death receptor 4 (red) and cell nuclei (blue). Image taken by Joshua Greenlee using a Zeiss LSM 880 from the Vanderbilt Cell Imaging Shared Resource Center. By Marissa Shapiro THE IDEA Vanderbilt faculty and researchers are looking for the “Achilles’ heel” of the cancer cells... Read More

Chemoresistant SW480 colon cancer cells stained for lipid rafts (green), death receptor 4 (red) and cell nuclei (blue). Image taken by Joshua Greenlee using a Zeiss LSM 880 from the Vanderbilt Cell Imaging Shared Resource Center. By Marissa Shapiro THE IDEA Vanderbilt faculty and researchers are looking for the “Achilles’ heel” of the cancer cells... Read More

Vanderbilt researchers discover that protein-coated nanoparticles kill more than half of cancer cells in the blood of patients with advanced chemo-resistant colon cancer. Est. reading time: 2.5 mins. Read More

Vitamin D protection against colon cancer varies according to parathyroid hormone response, particularly among women. Read More

Vanderbilt epidemiologists identified new markers for colorectal cancer risk and characterized a previously unidentified tumor suppressor that regulates overall tumor volume in vivo. Read More

Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients. Read More

Red and processed meat intakes are strongly associated with increased risk of sessile serrated polyps, which are not as well studied as conventional adenomas. Read More

Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer. Read More

Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States. Anna Means, Ph.D., and colleagues have now linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4. Read More

Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered. Read More

Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance. Read More

Bile acids produced by a western diet alter the composition of the gut microbiota and promote intestinal carcinogenesis. Read More

March is National Colon Cancer Awareness Month. As a department, group-decorate your work area in blue to raise awareness for colon cancer screening. We want to see how you would remind people that colon cancer screening should begin at age 50. Read More

Wear blue March 3 to show your support and raise awareness of colon cancer. Use this day to spread the word about colon cancer screening. Read More

Lifestyle factors like cigarette smoking and red meat consumption are known to be associated with an increased risk of colon polyps that can lead to colorectal cancer. Read More

For some people, cancer—especially colon cancer—is a persistent and potentially deadly visitor affecting family members from one generation to the next. Vanderbilt-Ingram Cancer Center, in partnership with the Colon Cancer Alliance, is hosting a free seminar to educate the public about risk factors associated with the disease. Read More

For some people cancer, especially colon cancer, is a persistent and potentially deadly visitor affecting family members from one generation to the next. Individuals who have a parent, sibling or child diagnosed with colon cancer have double the risk of developing the disease. Read More

A cancer patient’s gratitude toward his Vanderbilt-Ingram Cancer Center (VICC) physician led to a star-studded concert to benefit the Cancer Center. Read More

Visit the Scope Out Colon Health Expo from 11 a.m. to 1 p.m. Tuesday, March 22, in the Light Hall North Lobby to learn more about prevention, screenings and more. Read More